25 Results

People

  1. Mailankody
    Mailankody
  2. Hassoun
    Hassoun
  3. Lesokhin
    Lesokhin
  4. Korde
    Korde
  5. Shah
    Shah
  6. Tan
    Tan
  7. Hultcrantz
    Hultcrantz
  8. Derkach
    Derkach
  9. Giralt
    Giralt
  10. Landau
    Landau

Groups

  1. Biostatistics Service (25)
  2. Center for Hematologic Malignancies (25)
  3. Department of Medicine (25)
  4. Epidemiology and Biostatistics (25)
  5. Hematologic Malignancies, Division of (25)
  6. Myeloma (25)
  7. Hematologic Malignancies Research (23)
  8. Survivorship Research (23)
  9. CTCR Scholars (22)
  10. Sloan Kettering Institute Postdocs (22)
  1. "Biostatistics Service"
  2. "Sham Mailankody"
  3. "2022"
Formats
  1. Meeting Abstract (15)
  2. Journal Article (6)
  3. Correspondence (2)
  4. Research Letter (2)
Groups
  1. Biostatistics Service (25)
  2. Center for Hematologic Malignancies (25)
  3. Department of Medicine (25)
  4. Epidemiology and Biostatistics (25)
  5. Hematologic Malignancies, Division of (25)
  6. Myeloma (25)

More Groups

People
  1. Sham Mailankody (25)
  2. Alexander Lesokhin (23)
  3. Hani Hassoun (23)
  4. Malin Hultcrantz (22)
  5. Neha Korde (22)
  6. Urvi Shah (22)

More People

Years
  1. 2022 (25)
Publications
  1. Blood (7)
  2. Clinical Lymphoma, Myeloma and Leukemia (5)
  3. Journal of Clinical Oncology (3)
  4. Leukemia and Lymphoma (3)
  5. Blood Cancer Journal (1)
  6. British Journal of Haematology (1)

More Publications

Publishers
  1. American Society of Hematology (7)
  2. Elsevier Inc. (5)
  3. American Society of Clinical Oncology (3)
  4. Taylor & Francis Group (3)
  5. American Medical Association (2)
  6. American Association for Cancer Research (1)

More Publishers

Results (25)


Citation style sort is year ascending, and then by author or title. Author ascending is default.
  • A pilot plant based dietary intervention in MGUS and SMM is feasible and associated with reduction in insulin and leptin levels
    Meeting Abstract

    Shah, U.; Castro, F.; Anuraj, A.; Blaslov, J.; Adintori, P.; Derkach, A.; Pollak, M.; Maclachlan, K.; Mailankody, S.; Korde, N.; more...
    Clinical Lymphoma, Myeloma and Leukemia (2022)

    Fulltext@MSK | Save
  • Bone remineralization of lytic lesions in newly diagnosed multiple myeloma (NDMM) patients treated with carfilzomib, lenalidomide, dexamethasone +/- daratumumab induction regimen
    Meeting Abstract

    Meseha, M.; Abusamra, M.; Farooki, A.; Derkach, A.; Maclachlan, K.; Hultcrantz, M.; Hassoun, H.; Shah, U.; Lu, S.; Mailankody, S.; more...
    Clinical Lymphoma, Myeloma and Leukemia (2022)

    Fulltext@MSK | Save
  • Evaluating serum free light chain ratio as a biomarker for multiple myeloma
    Meeting Abstract

    Akhlaghi, T.; Maclachlan, K.; Korde, N.; Mailankody, S.; Lesokhin, A.; Hassoun, H.; Lu, S.; Patel, D.; Shah, U.; Tan, C.; more...
    Clinical Lymphoma, Myeloma and Leukemia (2022)

    Fulltext@MSK | Save
  • African American patients with smoldering multiple myeloma may have a lower risk of progression compared to white patients
    Meeting Abstract

    Akhlaghi, T.; Maclachlan, K.; Korde, N.; Mailankody, S.; Lesokhin, A.; Hassoun, H.; Lu, S.; Patel, D.; Shah, U.; Tan, C.; more...
    Clinical Lymphoma, Myeloma and Leukemia (2022)

    Fulltext@MSK | Save
  • Assessment of renal outcome following therapy in monoclonal immunoglobulin deposition disease: A retrospective study of 34 patients highlighting the need for consensus criteria
    Meeting Abstract

    Pianko, M. J.; Tiutan, T.; Derkach, A.; Jaffer-Sathick, I.; Rossi, A.; Salvatore, S.; Landau, H.; Lahoud, O.; Korde, N.; Mailankody, S.; more...
    Clinical Lymphoma, Myeloma and Leukemia (2022)

    Fulltext@MSK | Save
  • Belantamab mafodotin in patients with relapsed/refractory multiple myeloma, a real-world single center experience
    Meeting Abstract

    Hultcrantz, M.; Derkach, A.; Hassoun, H.; Korde, N.; Maclachlan, K. H.; Mailankody, S.; Patel, D.; Shah, U. A.; Tan, C.; Akhlaghi, T.; more...
    Blood (2022)

    Fulltext@MSK | Save
  • A randomized placebo controlled study of a plant-based dietary versus supplement versus placebo intervention in patients with monoclonal gammopathy of undetermined significance (MGUS) and smoldering multiple myeloma (SMM) - the Nutrition Prevention (NUTRIVENTION-3) study
    Meeting Abstract

    Shah, U. A.; Castro, F.; Anuraj, A.; Schach, E.; Derkach, A.; Joseph, N. S.; Adintori, P. A.; Guttentag, L.; Blaslov, J.; Cross, J. R.; more...
    Blood (2022)

    Fulltext@MSK | Save
  • A pilot plant based dietary intervention in MGUS and SMM patients with elevated BMI is feasible and associated with improvements in metabolic and microbiome biomarkers of progression
    Meeting Abstract

    Shah, U. A.; Derkach, A.; Castro, F.; Anuraj, A.; Blaslov, J.; Tran, L.; Adintori, P. A.; Burge, M.; Funkhouser, S.; Hosszu, K.; more...
    Blood (2022)

    Fulltext@MSK | Save
  • A phase 2 trial of colesevelam for lenalidomide-associated diarrhea
    Meeting Abstract

    Hultcrantz, M.; Hassoun, H.; Korde, N.; Mailankody, S.; Shekarkhand, T.; Burge, M.; Maclachlan, K. H.; Patel, D.; Shah, U. A.; Chung, D. J.; more...
    Blood (2022)

    Fulltext@MSK | Save
  • Maintenance Therapy Cessation for Sustained MRD Negative Multiple Myeloma Patients
    Meeting Abstract

    Korde, N.; Diamond, B.; Burge, M.; Hassoun, H.; Landau, H.; Hultcrantz, M.; Mailankody, S.; Maclachlan, K. H.; Shah, U. A.; Derkach, A.; more...
    Blood (2022)

    Fulltext@MSK | Save